Authors:
CANTAROVICH M
BESNER JG
BARKUN JS
ELSTEIN E
LOERTSCHER R
Citation: M. Cantarovich et al., 2-HOUR CYCLOSPORINE LEVEL DETERMINATION IS THE APPROPRIATE TOOL TO MONITOR NEORAL THERAPY, Clinical transplantation, 12(3), 1998, pp. 243-249
Authors:
BRUGADA R
KELSEY W
LECHIN M
ZHAO GL
YU QT
ZOGHBI W
QUINONES M
ELSTEIN E
OMRAN A
RAKOWSKI H
WIGLE D
LIEW CC
SOLE M
ROBERTS R
MARIAN AJ
Citation: R. Brugada et al., ROLE OF CANDIDATE MODIFIER GENES ON THE PHENOTYPIC-EXPRESSION OF HYPERTROPHY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, Journal of investigative medicine, 45(9), 1997, pp. 542-551
Citation: E. Elstein et C. Huan, POLYMORPHISMS FOR ANGIOTENSIN-CONVERTING ENZYME, ANGIOTENSINOGEN, NITRIC-OXIDE SYNTHASE, AND ENDOTHELIN AND THEIR ASSOCIATION WITH CARDIAC ALLOGRAFT VASCULOPATHY IN THE FIRST YEAR POSTTRANSPLANT, Transplantation proceedings, 29(6), 1997, pp. 2575-2575
Citation: E. Elstein et C. Huan, POLYMORPHISMS FN GENES OF ANGIOTENSIN-CONVERTING ENZYME, ANGIOTENSINOGEN, NITRIC-OXIDE SYNTHASE, AND ENDOTHELIN AND THEIR ASSOCIATION WITH CARDIAC ALLOGRAFT-REJECTION, Transplantation proceedings, 29(6), 1997, pp. 2576-2576
Authors:
BACHINSKI LL
ELSTEIN E
IFEGWU JC
CZERNUSZEWICZ G
ABCHEE AB
DURAND JB
KRAHE R
PERLIN M
NOWAK NJ
SHOWS TB
ZHANG J
SOLE MJ
ROBERTS R
Citation: Ll. Bachinski et al., REFINED MAPPING OF A GENE FOR HYPERTROPHIC CARDIOMYOPATHY (HCM4) TO A3 CM INTERVAL NEAR D11S903, American journal of human genetics, 57(4), 1995, pp. 1064-1064